Skip navigation

Melasma

Melasma is a dark skin discoloration that appears on sun-exposed areas of the face.

Causes

Melasma is a very common skin disorder. Though it can affect anyone, young women with brownish skin tones are at greatest risk.

Melasma is often associated with the female hormones estrogen and progesterone. It is especially common in pregnant women, women who are taking birth control pills (oral contraceptives) and women taking hormone replacement therapy (HRT) during menopause.

Sun exposure is also a strong risk factor for melasma. The condition is particularly common in tropical climates.

Symptoms

Melasma doesn't cause any other symptoms besides skin discoloration but may be of great cosmetic concern.

A uniform brown color is usually seen over the cheeks, forehead, nose, or upper lip. It is most often symmetrical (matching on both sides of the face).

Exams and Tests

Your health care provider can usually diagnose melasma based upon the appearance of your skin. A closer examination using a Wood's lamp may help guide your treatment.

Treatment

Treatments may include:

  • Creams containing a combination of tretinoin, kojic acid, and azelaic acid have been shown to improve the appearance of melasma.
  • Your doctor may recommend chemical peels or topical steroid creams.
  • In severe cases, laser treatments can be used to remove the dark pigment.

Avoiding the sun and using sunscreen are key to preventing melasma.

Outlook (Prognosis)

Melasma often fades over several months after stopping birth control pills or HRT, or after delivering a child. It may return with additional pregnancies or use of these medications.

When to Contact a Medical Professional

Call your health care provider if you have persistent darkening of your face.

Prevention

Daily sunscreen use not only helps prevent melasma but is crucial in the prevention of skin cancer and wrinkles.

Alternative Names

Chloasma; Mask of pregnancy; Pregnancy mask

References

Habif TP. Light-related diseases and disorders of pigmentation. In: Habif TP, ed. Clinical Dermatology. 5th ed. St. Louis, Mo: Mosby Elsevier; 2009:chap 19.

Sood A, Tomecki KJ. Pigmentary disorders. In: Carey WD, ed. Cleveland Clinic: Current Clinical Medicine 2010. 2nd ed. Philadelphia, Pa: Saunders Elsevier; 2010.

Update Date: 10/3/2010

Updated by: Linda J. Vorvick, MD, Medical Director, MEDEX Northwest Division of Physician Assistant Studies, University of Washington, School of Medicine. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

A.D.A.M Quality Logo

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 1997-2012, A.D.A.M., Inc. Duplication for commercial use must be authorized in writing by ADAM Health Solutions.

A.D.A.M Logo